Hangzhou AGS Medtech (688581.SH): Some shareholders plan to reduce their total holdings by no more than 3%.
Angiese (688581.SH) announced that, due to the company's business arrangements, shareholder Xin Jianyuan intends to reduce the company's shares in total...
Hangzhou AGS Medtech (688581.SH) announced that, due to the company's operational arrangements, shareholder Xinjianyuan intends to collectively reduce its holdings of the company's shares by no more than 1.2147 million shares (or 1.50% of the total shares of the company), and shareholder Tianyuan Silicon Valley intends to collectively reduce its holdings of the company's shares by no more than 1.2147 million shares (or 1.50% of the total shares of the company).
Related Articles
Q TECH (01478) intends to sell 51% stake of its Indian subsidiary to Dixon, India for a total consideration of 5.53 billion Rupees.
JL Mag Rare-Earth (06680) announces profit growth expectation in the first half of the year, with a net profit attributable to shareholders of 3 billion to 3.35 billion yuan, a year-on-year increase of 151%-180%.
ACESO LIFE SCI (00474) is selling a total of 569 million shares of Huatian International Construction Investment.
Q TECH (01478) intends to sell 51% stake of its Indian subsidiary to Dixon, India for a total consideration of 5.53 billion Rupees.
JL Mag Rare-Earth (06680) announces profit growth expectation in the first half of the year, with a net profit attributable to shareholders of 3 billion to 3.35 billion yuan, a year-on-year increase of 151%-180%.
ACESO LIFE SCI (00474) is selling a total of 569 million shares of Huatian International Construction Investment.
RECOMMEND
Jensen Huang Confirms NVIDIA to Begin H20 Chip Shipments to China
15/07/2025
Manus Exits China Market Amid $500 Million Valuation, Prompting Concerns Over AI Agent Sector Outlook
15/07/2025
Trump to Allocate $70 Billion in AI and Energy Investment, Escalating the Race for Technological Dominance
15/07/2025
